Terms: = Brain cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Clinical Outcome
3 results:
1. Controlling nutritional status score and prognostic nutrition index predict the outcome after severe traumatic brain injury.
Li Y; Liu C; Luo X; He Q; Cheng Y; Shen W; Xie Z
Nutr Neurosci; 2022 Apr; 25(4):690-697. PubMed ID: 32778001
[TBL] [Abstract] [Full Text] [Related]
2. miRNA-26a expression influences the therapy response to carmustine wafer implantation in patients with glioblastoma multiforme.
Sippl C; Ketter R; Braun L; Teping F; Schoeneberger L; Kim YJ; List M; Nakhoda A; Wemmert S; Oertel J; Urbschat S
Acta Neurochir (Wien); 2019 Nov; 161(11):2299-2309. PubMed ID: 31478117
[TBL] [Abstract] [Full Text] [Related]
3. First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial.
Lee SM; Khan I; Upadhyay S; Lewanski C; Falk S; Skailes G; Marshall E; Woll PJ; Hatton M; Lal R; Jones R; Toy E; Chao D; Middleton G; Bulley S; Ngai Y; Rudd R; Hackshaw A; Boshoff C
Lancet Oncol; 2012 Nov; 13(11):1161-70. PubMed ID: 23078958
[TBL] [Abstract] [Full Text] [Related]
